Remedium Lifecare Ltd: At the time of market closing on Monday, BSE Sensex was working at 72,708.16 points, which was up by 281.52 points, and Nifty was at 22,122.25 points. This was an increase of 81.55 points.
In the bullish phase of the market, share price of Remedium Life Care Limited registered an increase nearly 20 percent upper circuit.
Its shares with an estimated market capitalization of Rs 1400 crore crossed the threshold of 700 rupees during the trading on Monday.
The 52-week high in Remedium Life Care Limited share was at Rs 898, while the 52-week low level is 35.
In the past 5 months, Remedium Life Care shares have returned 51 percent to the investors as in the previous month, it has provided a return of 32 percent.
The share of Remedium Life Care has given an average return of 1675 percent for investors over the past year, and on February 20, shares had risen to the threshold of Rs 700 from a low of Rs 39.
The shares of Remedium Life Care had seen an all-time low of 2.75 on the 25th of February, 2019 which is the point at which the capital of investors has grown by over 25120 percent.
From the low of 2.25 that was recorded on the 25th of May, 2018 Remedium Life Care shares have given a huge yield of 30,526.67% to the investors.
Remedium Lifecare Limited is involved in the trade of pharmaceutical products such as Advanced Pharmaceutical Intermediates. Remedium Life Care Limited deals with the trading of APIs and intermediates.
The company offers APIs and additional intermediates for pharmaceutical players in both global and domestic corporations.
Remedium Life Care Ltd company has set the date of record for bonus shares to be the 28th of July in 2023.
After that, the company released shares at a ratio of 1:2 (stock divided). The company fixed the date for the split of shares as September 1st, 2023.
Before that, the company gave bonus shares to shareholders in a ratio of 9:5.
About Remedium Lifecare Ltd Company
Remedium Lifecare Limited is an Indian-based pharmaceutical company. It was founded in 1988.
The company is involved in trading with Advanced Pharmaceutical Intermediates and other pharmaceutical products.
The company operates in two divisions: Products and Services. The product segments comprise the trading and selling of pharmaceutical active ingredients (APIs) along with intermediates, to generic and innovative pharmaceutical companies.
The products offered by the company include diisopropylamine, Cyclohexane, and ethyl acetate.
Fundamental Analysis of Remedium Lifecare Ltd
| Market Cap | ₹ 1,389 Cr. |
| Current Price | ₹ 689.10 |
| 52-wk High | ₹ 898.30 |
| 52-wk Low | ₹ 35.32 |
| Stock P/E | 18.33 |
| Book Value | ₹ 11.0 |
| Dividend | 0.00 % |
| ROCE | 103 % |
| ROE | 71.0 % |
| Face Value | ₹ 5.00 |
| P/B Value | 62.8 |
| OPM | 2.42 % |
| EPS | ₹ 26.2 |
| Debt | ₹ 1.18 Cr. |
| Debt to Equity | 0.05 |
Remedium Lifecare Share Price Target 2024 To 2030
| Year | 1st Target | 2nd Target |
| 2024 | ₹700 | ₹738 |
| 2025 | ₹784 | ₹822 |
| 2026 | ₹832 | ₹898 |
| 2027 | ₹900 | ₹912 |
| 2028 | ₹925 | ₹945 |
| 2029 | ₹950 | ₹975 |
| 2030 | ₹1000 | ₹1211 |
Remedium Lifecare Ltd Shareholding Pattern
| Promoters Holding | |
| Dec 2022 | 1.11% |
| Mar 2023 | 1.11% |
| June 2023 | 1.11% |
| Sept 2023 | 1.11% |
| Dec 2023 | 1.11% |
| FII Holding | |
| Dec 2022 | 0.00% |
| Mar 2023 | 0.00% |
| June 2023 | 0.04% |
| Sept 2023 | 0.08% |
| Dec 2023 | 0.04% |
| Public Holding | |
| Dec 2022 | 98.88% |
| Mar 2023 | 98.88% |
| June 2023 | 98.84% |
| Sept 2023 | 98.81% |
| Dec 2023 | 98.86% |
Remedium Lifecare Ltd Share: Last 5 Years’ Financial Condition
To gain a better understanding of how the market is performing, let’s look at the outlook of this share in the previous years.
However, investors should be aware of the risks and the market conditions before making any investment decision.
Last 5 Years’ Sales:
| 2019 | ₹ 0 Cr |
| 2020 | ₹ 3 Cr |
| 2021 | ₹ 90 Cr |
| 2022 | ₹ 505 Cr |
| 2023 | ₹ 2,709 Cr |
Last 5 Years’ Net Profit:
| 2019 | ₹ 0 Cr |
| 2020 | ₹ 0 Cr |
| 2021 | ₹ 0 Cr |
| 2022 | ₹ 1 Cr |
| 2023 | ₹ 53 Cr |
Last 5 Years’ Debt-To-Equity Ratio:
| 2019 | 0.02 |
| 2020 | 0.11 |
| 2021 | 2.72 |
| 2022 | 0 |
| 2023 | 0 |
Last 10 Years’ Profit Growth:
| 10 Years: | — |
| 5 Years: | 252% |
| 3 Years: | 169% |
| Current Year: | 400% |
Last 10 years’ Return on Equity (ROE):
| 10 Years: | — |
| 5 Years: | 33% |
| 3 Years: | 45% |
| Last Year: | 71% |
Sales Growth Over 10 Years:
| 10 Years: | — |
| 5 Years: | 329% |
| 3 Years: | 461% |
| Current Year: | 471% |
Conclusion
This article is a complete guide about Remedium Lifecare Ltd Share.
These information and forecasts are based on our analysis, research, company fundamentals and history, experiences, and various technical analyses.
Also, We have talked in detail about the share’s future prospects and growth potential.
Hopefully, these informations will help you in your further investment.
If you are new to our website and want to get all the latest updates related to the stock market, join us on Telegram Group.
If you have any further queries, please comment below. We will be happy to answer all your questions.
If you like this information, share the article with as many people as possible.
Disclaimer: Dear readers, we’d like to inform you that we are not authorized by SEBI (Securities and Exchange Board of India). The information on this site is only for informational and educational purposes and shouldn’t be considered financial advice or stock recommendations. Also, the share price predictions are completely for reference purposes. The price predictions will only be valid when there are positive signs on the market. Any uncertainty about the company’s future or the current state of the market will not be considered in this study. We are not responsible for any financial loss you might incur through the information on this site. We are here to provide timely updates about the stock market and financial products to help you make better investment choices. Do your own research before any investment.
